Lucas Lee is a seasoned professional in the bioanalytical and drug development field, currently serving as a Senior Bioanalytical Scientist at QPS Holdings, LLC since August 2021. Leading a research and development team, Lucas oversees GLP-compliant bioanalytical and DMPK studies for various pharmaceutical companies, with a focus on preclinical LC-MS/MS method development and PK/PD data interpretation. Previously, Lucas held the position of Bioanalytical Lead at Agios Pharmaceuticals, contributing significantly to high-profile projects such as the NDA for TIBSOVO® and the development of large molecule quantitation platforms. Prior roles include Senior Scientist at Takeda Pharmaceuticals America, where LC-MS/MS methods for small molecule drugs were developed and validated, and Program Manager at Takeda Pharmaceuticals in Taiwan. Lucas began a career as a Scientist at Cereon Genomics, focusing on high-throughput metabolite profiling. Educational qualifications include a Master of Science in Biological Sciences from Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices